August 2026– date –
-
Market Trends
US States Restrict Cultivated Meat Labeling, Intensifying Legal Conflict Over Food Policy and Federal Approval
Food Policy Watch (Facebook repost) USA Overview Several U.S. states are imposing restrictions on the labeling of federally approved cultivated meat products, escalating a legal conflict between state and federal food policies. States li... -
Market Trends
AI Accelerates Biosimilar Comparability: Precise Detection of Structural Changes via HDX-MS and 2D-NMR Data Analysis
Pharma Advancement USA Overview AI integration is significantly accelerating comparability assessments in biosimilar development. Machine learning algorithms are trained to detect sub-nanometer, high-order structural changes from complex... -
Cell Culture Technology
Japan Approves World’s First iPSC-Derived Therapies ‘ReHeart’ for Heart Failure and ‘Amchepry’ for Parkinson’s Disease
Science Today Japan Overview Japan has granted the world's first approvals for groundbreaking induced pluripotent stem cell (iPSC)-derived therapies: 'ReHeart' for heart failure and 'Amchepry' for Parkinson's disease. These treatments ai... -
New Technology
Digital Twins Poised to Eclipse Traditional Scale-Up Models in Bioprocess Development
Pharma's Almanac USA Overview Pharma's Almanac suggests that digital twin technology may significantly outperform traditional models in bioprocess scale-up. Digital twins integrate process models with manufacturing and experimental data,... -
New Technology
Lonza Launches ‘RaMP’ Service, Accelerating Custom Media Supply to 10 Business Days for Early Bioprocess Development
Manufacturing Chemist Switzerland Overview Lonza has launched its Rapid Custom Media Prototyping (RaMP) service to significantly accelerate early bioprocess development. This new offering allows biopharmaceutical companies to receive cus... -
Cell Culture Technology
4basebio and Genezen Partnership Revolutionizes Viral Vector Manufacturing: Cell-Free Synthetic DNA Reduces Costs by 30%
BioPharm International USA Overview 4basebio and viral vector CDMO Genezen announced a partnership to integrate 4basebio's cell-free hpDNA platform into Genezen's manufacturing workflow. This innovative technology enzymatically produces ... -
New Technology
Frontiers Advocates for Animal-Free Media in Cell Culture to Enhance Reproducibility
Frontiers Switzerland Overview An editorial in Frontiers emphasizes the critical importance of adopting animal-free and chemically defined media for enhancing the reliability and reproducibility of in vitro cell culture experiments. Whil... -
New Technology
Single-Use Mixing Solutions in Bioprocessing: Optimizing Processes with Digital Twins and AI
Industry Insight (Facebook repost) Unknown Overview The selection of single-use mixing solutions in bioprocess engineering is crucial for process optimization, driven by the integration of advanced technologies like digital twins, AI, ma... -
Cell Culture Technology
REPROCELL Enables Clinical-Scale iPSC Manufacturing with StemEdit and Bioreactor Technologies
REPROCELL Japan Overview REPROCELL is facilitating a seamless transition from lab-scale iPSC manufacturing to GMP production and clinical application by integrating its StemEdit gene-editing platform with ABLE Biott and BioThrust bioreac... -
Cell Culture Technology
KOLON Biotech Boosts End-to-End CDMO Services for Advanced Cell, Gene, and Exosome Therapies in South Korea
MTEC South Korea Overview South Korea's KOLON Biotech is enhancing its comprehensive CDMO services, specializing in advanced cell, gene, and exosome therapies. The company offers end-to-end solutions, from technology transfer and process...